Mark Twyman

Mark Twyman is the Vice President of Commercial at Inovio Pharmaceuticals. Mark has over 15 years of experience in the pharmaceutical industry, with a focus on marketing and commercialization. Prior to joining Inovio, they were the VP of Marketing at Novavax, where they led the development and launch of the RSV vaccine for older adults. Mark also served as the Senior Director of Commercial at Inovio Pharmaceuticals, where they oversaw the commercialization of Inovio's products.

Mark Twyman has a MBA from The Wharton School. Their focus was in finance and marketing.

Their manager is J. Joseph Kim, President & CEO. Some of their coworkers include Robert J. Juba Jr. - Vice President, Biological Manufacturing and Clinical Supply Management, Jeffrey Skolnik - Vice President, Clinical Development, and Peter Kies - Chief Financial Officer.